An ex vivo lung model to study bronchioles infected with Pseudomonas aeruginosa biofilms by Harrison, Freya & Diggle, Stephen P.
Harrison, Freya and Diggle, Stephen P. (2016) An ex 
vivo lung model to study bronchioles infected with 
Pseudomonas aeruginosa biofilms. Microbiology, 162 . 
pp. 1755-1760. ISSN 1465-2080 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/35952/1/mic.0.000352.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
This article is made available under the University of Nottingham End User licence and may 
be reused according to the conditions of the licence.  For more details see: 
http://eprints.nottingham.ac.uk/end_user_agreement.pdf
A note on versions: 
The version presented here may differ from the published version or from the version of 
record. If you wish to cite this item you are advised to consult the publisher’s version. Please 
see the repository url above for details on accessing the published version and note that 
access may require a subscription.
For more information, please contact eprints@nottingham.ac.uk
Downloaded from www.microbiologyresearch.org by
IP:  128.243.2.140
On: Mon, 22 Aug 2016 12:29:51
Microbiology
 
An ex vivo lung model to study bronchioles infected with Pseudomonas aeruginosa
biofilms
--Manuscript Draft--
 
Manuscript Number: MIC-D-16-00233R2
Full Title: An ex vivo lung model to study bronchioles infected with Pseudomonas aeruginosa
biofilms
Short Title: Bronchiolar biofilms of Pseudomonas aeruginosa in ex vivo lung
Article Type: Standard
Section/Category: Host-microbe interaction
Corresponding Author: Freya Harrison
University of Warwick
UNITED KINGDOM
First Author: Freya Harrison
Order of Authors: Freya Harrison
Stephen P. Diggle
Abstract: A key aim in microbiology is to determine the genetic and phenotypic bases of bacterial
virulence, persistence and antimicrobial resistance in chronic biofilm infections. This
requires tractable, high-throughput models that reflect the physical and chemical
environment encountered in specific infection contexts. Such models will increase the
predictive power of microbiological experiments and provide platforms for enhanced
testing of novel antibacterial or antivirulence therapies. We present an optimised ex
vivo model of cystic fibrosis lung infection: ex vivo culture of pig bronchiolar tissue in
artificial cystic fibrosis mucus. We focus on the formation of biofilms by Pseudomonas
aeruginosa. We show highly repeatable and specific formation of biofilms that
resemble clinical biofilms by a commonly-studied lab strain and ten cystic fibrosis
isolates of this key opportunistic pathogen.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Downloaded from www.microbiologyresearch.org by
IP:  128.243.2.140
On: Mon, 22 Aug 2016 12:29:51
 1 
An ex vivo lung model to study bronchioles infected with Pseudomonas 1 
aeruginosa biofilms 2 
Running title: Bronchiolar biofilms of Pseudomonas aeruginosa in ex vivo lung 3 
 4 
Freya Harrison1,2* & Stephen P. Diggle1 5 
 6 
1Centre for Biomolecular Sciences, School of Life Sciences, University of Nottingham, Nottingham, 7 
United Kingdom 8 
2Current address: School of Life Sciences, University of Warwick, Coventry, United Kingdom 9 
 10 
*Author for correspondence. Email: F.Harrison@warwick.ac.uk Tel: +44(0)24 7657 4251 11 
 12 
 13 
 14 
Key words biofilm; 3Rs; chronic infection; cystic fibrosis; respiratory infection; Pseudomonas 15 
aeruginosa 16 
Article type Research paper 17 
Subject category Host-microbe interaction 18 
 19 
Word count 2,895 20 
 21 
Abbreviations EVPL: ex vivo pig lung 22 
 23 
 24 
  25 
Manuscript Click here to download Manuscript Including References
(Word document) harrisondiggle_revised.docx
Downloaded from www.microbiologyresearch.org by
IP:  128.243.2.140
On: Mon, 22 Aug 2016 12:29:51
 2 
Abstract 26 
A key aim in microbiology is to determine the genetic and phenotypic bases of bacterial virulence, 27 
persistence and antimicrobial resistance in chronic biofilm infections. This requires tractable, high-28 
throughput models that reflect the physical and chemical environment encountered in specific 29 
infection contexts. Such models will increase the predictive power of microbiological experiments 30 
and provide platforms for enhanced testing of novel antibacterial or antivirulence therapies. We 31 
present an optimised ex vivo model of cystic fibrosis lung infection: ex vivo culture of pig 32 
bronchiolar tissue in artificial cystic fibrosis mucus. We focus on the formation of biofilms by 33 
Pseudomonas aeruginosa. We show highly repeatable and specific formation of biofilms that 34 
resemble clinical biofilms by a commonly-studied lab strain and ten cystic fibrosis isolates of this 35 
key opportunistic pathogen.  36 
 37 
 38 
  39 
Downloaded from www.microbiologyresearch.org by
IP:  128.243.2.140
On: Mon, 22 Aug 2016 12:29:51
 3 
Introduction 40 
 41 
Chronic lung infections are debilitating, highly antibiotic resistant and often lethal. They affect 42 
people with chronic obstructive pulmonary disease, ventilator-associated pneumonia, HIV/AIDS 43 
and the genetic disorder cystic fibrosis (CF). Chronic lung infections are caused by communities of 44 
different microbial genotypes and species (Short et al., 2014), but the formation of bacterial 45 
biofilms in the airways is a key factor in producing a persistent and difficult to treat infection. CF 46 
lung infections are perhaps the epitome of intractable biofilm infection: they last for decades and 47 
the majority of people with CF die from respiratory failure, 50% of them before reaching middle age 48 
(Elborn, 2016). Understanding the basic in vivo microbiology of key CF pathogens is a vital step 49 
towards designing effective treatment. Much research and clinical effort focuses on the 50 
opportunistic bacterial pathogen Pseudomonas aeruginosa, which eventually colonises most 51 
people with CF, is a primary target for antimicrobial treatment, and forms extensive biofilm plugs in 52 
the patient’s bronchioles (Bjarnsholt et al., 2009; Elborn, 2016). 53 
 54 
Various in vitro systems and insect or rodent hosts are used to study P. aeruginosa and to 55 
determine the genetic and phenotypic variables that determine virulence and persistence. 56 
However, most in vitro experiments use unstructured broth cultures, or grow biofilms that are 57 
attached to abiotic surfaces and whose structure is very different from those seen in vivo (Roberts 58 
et al.; Bjarnsholt et al., 2013). Insect hosts have limited similarity to humans and it is now clear that 59 
rodent tissue chemistry (Benahmed et al., 2014) and immune responses (Seok et al., 2013) differ 60 
significantly from those of humans. In vivo experiments are also limited in duration (acute or semi-61 
chronic) due to restrictions imposed by ethical concerns, cost and host response to disease (Wiles 62 
et al., 2006; Hoffmann, 2007; Kukavica-Ibrulj and Levesque, 2008). In general, the environment 63 
during chronic infection differs from that encountered in a healthy host (acute infection). Tissue 64 
damage and disease-specific changes in host phenotype cause physical differences, e.g. 65 
increased mucus volume and adhesivity in CF. The chemical environment also differs as different 66 
substrates for growth become available: in CF, bacteria use amino acids released by damaged 67 
tissues, or from mucus, as carbon sources, and do not experience the iron restriction characteristic 68 
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of healthy tissue (Tyrrell and Callaghan, 2016). Consequently, gene expression and the roles 69 
played by virulence factors differ in chronic vs. acute contexts (Palmer et al., 2005; LaFayette et 70 
al., 2015; Turner et al., 2015). Environmental cues also affect antibiotic resistance phenotypes: P. 71 
aeruginosa grown in synthetic CF sputum upregulates an antibiotic efflux pump (Tata et al., 2016). 72 
The extent of environmental change as an infection progresses from acute to chronic is underlined 73 
by the extent to which P. aeruginosa and other pathogens evolve and diversify over the course of 74 
CF lung infection. In particular, clones with mutations in genes associated with virulence in acute 75 
infection are commonly recovered from chronically-infected patients (Smith et al., 2006; Diaz 76 
Caballero et al., 2015; Silva et al., 2016).  A general lack of chronicity and realistic tissue chemistry 77 
therefore limits the use of in vitro and rodent models for investigating pathogen biology, and 78 
arguably explains the high failure rate in translating proposed new drugs from animal models to the 79 
clinic (McGonigle and Ruggeri, 2014).  80 
 81 
Cheap, high-throughput models of lung biofilm that carefully recapitulate the physical and chemical 82 
environment encountered in chronic CF infection are not well represented in the microbiologist’s 83 
toolkit. Such models would drastically increase the level of biological realism achievable in the 84 
laboratory and so open a new window to help us study the in vivo biofilm. They could be used to 85 
reveal novel targets for clinical intervention, to test promising new anti-biofilm or anti-bacterial 86 
compounds, or for more predictive diagnostic tests of antibiotic resistance.  87 
 88 
Inspired by previously published work (Williams and Gallagher, 1978; Nunes et al., 2010), we  89 
recently developed a cheap, high-throughput protocol (Harrison et al., 2014) for infecting ex vivo 90 
pig lung tissue (EVPL) with P. aeruginosa and culturing these model infections in conditions that 91 
mimic the chemistry of chronically-infected CF lung mucus (artificial sputum medium (Palmer et al., 92 
2007)). Pigs have more similar lung structure, immunology and chemistry to humans than do mice 93 
(Meurens et al., 2012; Benahmed et al., 2014) and lung tissue is available as a by-product from the 94 
meat industry, so the model poses no ethical concerns. The model is cheap and allows for high 95 
levels of replication: several dozen individual pieces of tissue can be dissected from each pair of 96 
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lungs. Because the lungs come from animals certified fit for human consumption, the model also 97 
poses no obvious biological safety risks. 98 
 99 
We showed that EVPL could be used to compare the growth, pathology and virulence of different 100 
genotypes of P. aeruginosa using cell counts, microscopy and quantitative chemical or reporter-101 
based assays for various virulence factors (quorum sensing signals, proteases, siderophores, 102 
pyocyanin). Reproducibility between tissue taken from independent lungs was high (Harrison et al., 103 
2014). We found that, while communication via quorum sensing is required for P. aeruginosa 104 
growth and virulence in acute infection models, this behaviour appears to be dispensable in EVPL 105 
(Harrison et al., 2014). This shows the importance of recognising and modelling environmental and 106 
ecological differences in acute vs. chronic contexts.  107 
 108 
Our previous work used sections of alveolar lung tissue, corresponding to the location infection in a 109 
very late, pre-terminal stage of CF. In reality, long-term, prophylactic use of antibiotics results in P. 110 
aeruginosa biofilm remaining restricted to the bronchioles for most of the course of chronic 111 
infection (Bjarnsholt et al., 2009). We have therefore developed a version of our model that uses 112 
small sections of pig bronchiole to better represent P. aeruginosa biofilm during the long periods of 113 
relatively quiescent chronic infection that characterise CF.  114 
 115 
 116 
Methods 117 
 118 
Bacterial strains 119 
PAO1 and PA14 were used as examples of standard laboratory strains of P. aeruginosa. As 120 
exemplar chronic CF isolates, we selected ten clones taken from a single CF sputum sample that 121 
had previously been subjected to extensive phenotypic and genomic analysis in our laboratory and 122 
which belong to the Liverpool Epidemic Strain lineage (Darch et al., 2015). 123 
 124 
Artificial sputum medium and culture conditions 125 
Downloaded from www.microbiologyresearch.org by
IP:  128.243.2.140
On: Mon, 22 Aug 2016 12:29:51
 6 
Artificial sputum medium was prepared following the recipe of Palmer et al. (2007), with the 126 
modification that we did not add glucose to the medium. Preliminary work suggested that glucose 127 
facilitated growth of any resident bacteria left on the lung tissue, and did not affect the growth of P. 128 
aeruginosa when lung tissue was present. All media used in this work were supplemented with 50 129 
μg/ml ampicillin to further minimize the growth of any resident bacteria present in the lung tissue. 130 
(Preliminary work found that ampicillin did not significantly affect P. aeruginosa growth, but we 131 
would advise that any effect of ampicillin on bacterial colonisation or gene expression is explicitly 132 
tested for in future experiments where this may influence the results). 133 
 134 
Lung dissection & infection 135 
Pig lungs were obtained from a local butcher (JT Beedham & Sons, Nottingham). Lungs came 136 
from the butcher’s own herd of Duroc x Pietrain pigs, were collected as soon as possible after they 137 
arrived in the shop from the abattoir and were used immediately on arrival in the laboratory. Lungs 138 
were transported in a chilled coolbox to the University of Nottingham and dissected in a room not 139 
used for microbiological work. Standard sterile technique was observed at all times (work 140 
conducted under a Bunsen burner, dissection tools pre-sterilised by autoclaving and re-sterilised 141 
as necessary by dipping in ethanol and flaming). The ventral surface of the pleura was briefly (<1 142 
s) seared with a hot pallet knife to kill surface contaminants from the abattoir or butcher's shop. 143 
This also renders the pleura easier to cut. A mounted razor blade was used to cut into the tissue 144 
along the length of the first 5-10 cm of the right or left main bronchus, just deep enough to expose 145 
the cartilage of the bronchus. The exact length available varies between lungs depending on the 146 
size and how rapidly the bronchus branches; we recommend working with bronchi and bronchioles 147 
of 1-3 cm in diameter. A mounted razor blade was then used to make a transverse cut across the 148 
top of the bronchus to separate it from the trachea. By holding this free end, it is possible to use 149 
the razor blade to gently separate a length of bronchus from the surrounding alveolar tissue. 150 
Approx. 5 cm long sections of bronchus/bronchiole were removed in this way, and stripped of most 151 
remaining attached alveolar tissue using mounted razor blades. These sections were washed 152 
twice with a 1:1 mix of RPMI 1640 and Dulbecco's modified Eagle medium (DMEM) (Sigma-153 
Aldrich). Dissection scissors were used to trim away any remaining alveolar or connective tissue 154 
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on the surface of the bronchioles (this is softened and made easier to remove by washing). 155 
Scissors were then used to cut the washed bronchioles into longitudinal strips of approx. 5 mm 156 
width, and then to cut approx. 5 mm square sections from these strips. Any remaining excess 157 
alveolar or connective tissue was trimmed away with scissors as the bronchioles were being 158 
sectioned. Bronchiolar tissue sections were then washed once with a 1:1 mix of RPMI 1640 and 159 
DMEM, and once with ASM. Sections were transferred individual to the wells of 24-well tissue 160 
culture plate: each well contained a soft pad of 400 μl ASM supplemented with 0.8% w/v agarose. 161 
500 μl liquid ASM was added to each well. For imaging experiments only, smaller bronchioles (5 162 
mm – 1 cm diameter) were also dissected and whole cross-sections approx. 5 mm long were cut 163 
with a mounted razor blade. 164 
To inoculate bronchiolar sections with bacteria, a sterile hypodermic needle (29 or 30G) 165 
was lightly touched to the surface of a P. aeruginosa colony grown on an LB agar plate and then 166 
used to prick the bronchiolar tissue. For mock-infection controls, tissue was pricked with a sterile 167 
needle. We found that needles mounted on 1 ml insulin syringes were easy to handle safely and 168 
accurately. Tissue was incubated at 37°C on a rocking platform for up to 4 days. 169 
After incubation, tissue was rinsed in 1 ml phosphate buffered saline to remove loosely 170 
adhering cells. Tissue sections intended for microscopy were preserved in formalin, sectioned and 171 
stained with Gram stain or haematoxylin and eosin (H&E). Microscopy was conducted with a Nikon 172 
Eclipse 50i with Digital Sight DS-U3 camera. Tissue sections used to assay total bacterial numbers 173 
were homogenised individually in 500 μl phosphate-buffered saline in metal bead tubes (Cambio) 174 
using a Precellys24 homogenizer. Homogenates were serially diluted and aliquots plated on LB 175 
agar to obtain single colonies. 176 
 177 
Bead biofilm assay 178 
For each bacterial clone to be investigated, a sweep of colonies was taken from an LB agar plate, 179 
inoculated into 3ml ASM and cultured overnight at 37°C on an orbital shaker. Cultures were diluted 180 
to an OD600 of 0.1 in ASM and three replica 2ml aliquots transferred to 5 ml plastic universal tubes. 181 
A 9x6 mm plastic bead (pony beads from www.mailorder-beads.co.uk) was added to each tube 182 
and cultures incubated for 24 hours at 37°C on an orbital shaker at 200 rpm. Biofilms were 183 
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collected by retrieving the beads from the tubes, gently washing three times in 10 ml phosphate 184 
buffered saline, transferring to 10 ml fresh phosphate buffered saline and sonicating in a bath 185 
sonicator for 10 minutes. Recovered biofilm populations were diluted and plated on LB agar to 186 
count colonies. 187 
 188 
 189 
Results & Discussion 190 
 191 
Appearance of mock-infected and biofilm-colonised tissue 192 
Mock-infected bronchiolar EVPL retains normal histopathology for seven days (Fig. 1a). We used a 193 
sterile hypodermic needle to transfer colony-grown cells of a standard used lab strain of P. 194 
aeruginosa, PAO1, to EVPL and observed that after four days’ incubation in artificial sputum 195 
medium at 37°C, this strain formed dense, mucoid biofilms that are highly reminiscent of the sticky 196 
plugs that occlude CF patients’ bronchioles (Fig. 1b, c). Microscopy (Fig. 1c) showed that the four 197 
day old biofilm had numerous empty voids, giving it a spongy appearance: this is similar to images 198 
of P. aeruginosa biofilm in some samples of expectorated CF sputum (Fig. 1d in Bjarnsholt et al., 199 
2009) and in explanted CF lungs (Fig. 3 in Kragh et al., 2014), and of mucus plugs in the 200 
bronchioles of late-stage CF patients (Fig. 8 in Henderson et al., 2014). We noted that the 201 
bronchiolar tissue largely retained its integrity even when covered in large amounts of biofilm: the 202 
tissue was not dissolved or macerated by P. aeruginosa exoproducts. 203 
 204 
We then tested how clinical isolates of P. aeruginosa, that have adapted to a chronic lifestyle in CF 205 
lungs over many generations, performed in our model. We selected ten genetically and 206 
phenotypically diverse P. aeruginosa clones that were previously isolated in our lab from a single 207 
CF sputum sample (Darch et al., 2015) and cultured them in EVPL as described above. In parallel, 208 
we also cultured PAO1 and a second commonly-used lab strain, PA14. Three replica sections of 209 
tissue were inoculated for each strain (or used for the uninoculated control) and the whole 210 
experiment was replicated twice using two different lungs obtained on different days. As can be 211 
seen in the example photographs from lung A in Fig. 2, the CF isolates formed biofilm on 212 
Downloaded from www.microbiologyresearch.org by
IP:  128.243.2.140
On: Mon, 22 Aug 2016 12:29:51
 9 
bronchiolar tissue more rapidly and more specifically than the lab isolates. PA14 did not show 213 
visible growth either on the tissue or in the surrounding ASM at 19 hours post-inoculation, by which 214 
which time cultures of PAO1 and the CF isolates showed visible bacterial growth. However, while 215 
PAO1 had grown to high density in the liquid ASM surrounding the tissue, it did not at this early 216 
stage show any noticeable growth on the tissue itself. In contrast, by 19 hours post-inoculation, the 217 
CF isolates had formed frond-like aggregates on and connected to the cubes of tissue, without 218 
noticeable turbidity of the surrounding liquid medium. These observations are consistent with 219 
EVPL providing a permissive and therefore realistic environment for these lung-adapted clones. 220 
Fig. S1 shows replica bronchiolar biofilms of each of the ten CF isolates and two lab strains at 4 221 
days post-inoculation in lung B; comparable results were obtained in both lungs used. As with 222 
PAO1, the square of tissue retained its general shape and size, it was not destroyed by the 223 
colonising bacteria. 224 
 225 
Consistency of biofilm formation on bronchiolar EVPL versus a standard in vitro assay 226 
It is important to determine how reproducible experimental results are likely to be in any 227 
experimental model: more variable models will require greater sample sizes to measure microbial 228 
traits of interest, or to perform experiments with adequate statistical power to reject the null 229 
hypothesis. For example, if we want to test the null hypothesis that there is no difference in biofilm 230 
forming ability between different genotypes, it would be helpful to know the proportion of variation 231 
in biofilm formation that is due to differences among clones, as opposed to differences between 232 
replica populations of the same clone cultured on different pieces of tissue. In statistical language 233 
this measure of reproducibility is called the intraclass correlation coefficient – or, more informally, 234 
“repeatability” – and is easily calculated from the results of a one-way analysis of variance 235 
(ANOVA)  (Lessells and Boag, 1987). Therefore, we conducted an experiment with a deliberately 236 
small sample size to compare the repeatability of biofilm formation by ten clinical isolates of P. 237 
aeruginosa on bronchiolar EVPL and in an attachment assay using plastic beads that has become 238 
a standard in vitro assay for biofilm formation (Poltak and Cooper, 2011). We sought to determine 239 
how reproducibly each clone formed biofilm on different pieces of lung tissue, and to see how this 240 
level of reproducibility compared with that observed in the bead assay. 241 
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 242 
Each of the ten CF isolates previously used was cultured in triplicate in EVPL (tissue from a single 243 
lung) and in a well-establised bead biofilm assay. As can be seen from the error bars in Fig. 3, 244 
there was more within-clone variation in the bead assay than in the EVPL model. Consequently, 245 
the bacterial density recovered from EVPL showed higher repeatability (0.63 vs. 0.24). This 246 
allowed ANOVA to identify inter-clone differences in biofilm formation (F2,20=6.1, p<0.001) despite 247 
the small sample size; these were not apparent in the bead assay (F2,20=2.0, p=0.104) (Table 1). 248 
The comparative data in Fig. 3 also demonstrate the impressive thickness of the biofilm formed on 249 
a relatively small surface area of bronchiolar EVPL (approx. 50 mm2, compared with approx. 180 250 
mm2 for a bead). 251 
 252 
 Future value of EVPL as a laboratory model of biofilm infection 253 
In conclusion, we present a model for CF biofilm infection that facilitates cheap, high-throughput 254 
screening of P. aeruginosa clones in an environment which more closely mimics the structure and 255 
chemistry of chronically-infected lungs. In our previous work with alveolar sections of EVPL, we 256 
showed that a range of bacterial virulence factors can be quantified directly from infected tissue 257 
using luminescent reporter constructs and a range of standard fluorescence-based or colorimetric 258 
assays. All of these assays will also be possible with in situ populations grown on bronchiolar 259 
sections, or homogenates thereof. In the future, this model will be a valuable tool in increasing our 260 
understanding of the basic microbiology of biofilm infection and its clinical consequences. We have 261 
optimised this model for the study of CF, but with a few modifications such as context-specific  262 
culture media, the model could be transferrable to the study of a range of lung infection contexts. 263 
 264 
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 270 
Abbreviations  271 
EVPL: ex vivo pig lung 272 
 273 
Figure Legends 274 
Figure 1. (a) Uninfected bronchiolar EVPL retains structure after 7 days’ culture at 37°C in ASM 275 
(H&E stained cross-section of a small bronchiole tissue). (b) P. aeruginosa strain PAO1 forms 276 
extensive mucoid biofilm on squares of bronchiolar tissue by four days post-inoculation. The green 277 
pigmentation is typical of P. aeruginosa and is a mixture of the exoproducts pyoverdine and 278 
pyocyanin; note how the coating of bacteria drips from the tissue and sticks to the plastic culture 279 
plate as the section of bronchiole is lifted out of the well. (c) Microscopy confirms that the biofilms 280 
in (b) are a mass of Gram-negative (pink) rods. 281 
Figure 2. (a) EVPL in situ in ASM at 19 hours post-inoculation. Uninfected bronchiolar tissue 282 
retains its normal appearance: a pinkish-white square with no noticeable degradation, surrounded 283 
by clear ASM. The lab strain PA14 does not show visible growth either on the tissue or in the 284 
surrounding ASM at this early stage; PAO1, in contrast, has grown extensively in the liquid ASM 285 
surrounding the tissue (green-yellow pigmentation due to production of pyoverdine) but does not 286 
yet show any noticeable growth on the tissue itself – note pinkish-white square of tissue sitting in 287 
the liquid bacterial culture. In contrast, CF isolates of P. aeruginosa (e.g. SED-41, SED-43) show 288 
growth as frond-like aggregates on and connected to the cubes of tissue, very different from the 289 
dense planktonic growth of PAO1. (b) By 4 days post-inoculation, CF isolates of P. aeruginosa 290 
have grown to high density on EVPL. The image shows three replica infections of SED-41 (top 291 
row) and SED-43 (bottom row) after washing the tissue with phosphate-buffered saline to remove 292 
non-adhering cells: a coating of sticky P. aeruginosa, with blue-green pigmentation (pyoverdine 293 
and pyocyanin), is left behind. (c) These biofilms are noticeably mucoid (e.g. SED-41). 294 
Figure 3 Biofilm mass (colony forming units, CFU) recovered from plastic beads (grey bars) and 295 
from EVPL (white bars). 296 
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Figure S1. Replica biofilms formed by ten CF sputum isolates and two lab strains, shown at 4 days 297 
post-inoculation after washing in saline to remove loosely-adhering cells. Tissue is pictured in a 298 
standard 24-well culture plate; as two plates were required to grow three replicates of each clone, 299 
three replica uninoculated sections were placed in each plate. Nomenclature for the CF isolates is 300 
the same as in the first published article describing the phenotypic and genetic diversity of these 301 
isolates (Darch et al., 2015)). 302 
 303 
Tables 304 
Table 1 Analysis of Variance and repeatability (r) of biofilm mass for ten clinical P. aeruginosa 305 
isolates on (a) beads and (b) bronchiolar EVPL. Note that data for one replicate population of one 306 
clone in the bead assay was lost. 307 
 308 
(a) Beads 
      
 
d.f. Sum of Squares Mean Square F p r 
Clone 9 1.35E+11 1.50E+10 1.957 0.104 0.24 
Residuals 19 1.46E+11 7.66E+09 
   
       (b) EVPL 
      
 
d.f. Sum of Squares Mean Square F p r 
Clone 9 2.53E+18 2.81E+17 6.131 < 0.001 0.63 
Residuals 20 9.16E+17 4.58E+16 
     309 
  310 
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Figure S1. Replica biofilms formed by ten CF sputum isolates and two lab strains, shown at 4 days 
post-inoculation after washing in saline to remove loosely-adhering cells. Tissue is pictured in a 
standard 24-well culture plate; as two plates were required to grow three replicates of each clone, 
three replica uninoculated sections were placed in each plate. Nomenclature for the CF isolates is 
the same as in the first published article describing the phenotypic and genetic diversity of these 
isolates	  (Darch et al., 2015). 	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